Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-04

Clinical Trial Update: Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing nicotine sublingual tablets to Nicorette lozenges in healthy smokers. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicorette Lozenge (Nicotine)
  • Nicotine sublingual tablet (Nicotine)

Snippet

Sponsor: Friends Research Institute, Inc. | Conditions: Tobacco Use Disorder, Cigarette Smoking | Phase 1 | Status: COMPLETED